Canada Markets closed

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5670+0.0157 (+2.85%)
At close: 2:45PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 520.25M
Enterprise Value 325.48M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)24.01
Price/Book (mrq)5.97
Enterprise Value/Revenue 330.21
Enterprise Value/EBITDA 7-10.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.8940
52 Week Low 30.4620
50-Day Moving Average 30.5858
200-Day Moving Average 30.7322

Share Statistics

Avg Vol (3 month) 31.29k
Avg Vol (10 day) 3273
Shares Outstanding 535.55M
Implied Shares Outstanding 6N/A
Float 34.38M
% Held by Insiders 124.34%
% Held by Institutions 10.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr. 19, 2018
Ex-Dividend Date 4Mar. 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr. 19, 2018

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends May 30, 2020
Most Recent Quarter (mrq)Feb. 27, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-330.29%

Management Effectiveness

Return on Assets (ttm)-30.88%
Return on Equity (ttm)-85.93%

Income Statement

Revenue (ttm)843.38k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)124.78k
EBITDA -2.45M
Net Income Avi to Common (ttm)-2.99M
Diluted EPS (ttm)-0.0710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.43M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)2.03M
Total Debt/Equity (mrq)60.14
Current Ratio (mrq)2.41
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-2.87M
Levered Free Cash Flow (ttm)-925k